Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes

Blood Pressure

Volumn 19, Issue 3, 2010, Pages 196-205

  Biala, Agnieszka ^a   Tauriainen, Eveliina ^a   Siltanen, Antti ^a   Shi, Jin ^a   Merasto, Saara ^a   Louhelainen, Marjut ^a   Martonen, Essi ^a   Finckenberg, Piet ^a   Muller, Dominik N ^b   Mervaala, Eero ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Experimental and Clinical Research Center   (Germany)

Author keywords

Aging; Hypertension; Mitochondrial biogenesis; Nicotinamide; Reninangiotensinaldosterone system (RAAS); Resveratrol; SIRT1

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II; CYTOCHROME C OXIDASE; MESSENGER RNA; NICOTINAMIDE; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RENIN; RESVERATROL; SIRTUIN 1; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; GENE EXPRESSION; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; IN VITRO STUDY; MALE; MITOCHONDRION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; SURVIVAL RATE; TRANSGENIC RAT;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; GENES; HEART; HUMANS; HYPERTENSION; MALE; MITOCHONDRIA; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RENIN; RENIN-ANGIOTENSIN SYSTEM; STILBENES;

EID: 77952837883     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2010.481808     Document Type: Article

References (44)

1. Cheng ZJ, Vapaatalo H, Mervaala E. Angiotensin II and vascular infl ammation. Med Sci Monit. 2005;11:RA194 - RA205.
2. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res. 2006;71:247-258.
3. Verlohren S, Muller DN, Luft FC, Dechend R. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension. 2009;54:439-443.
4. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: Linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2008;102:488-496.
5. Westhoff JH, Hilgers KF, Steinbach MP, Hartner A, Klanke B, Amann K, Melk A. Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension. 2008;52:123-129.
6. Boily G, Seifert EL, Bevilacqua L, He XH, Sabourin G, Estey C, et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One. 2008;3:e1759.
7. Hasegawa K, Yoshikawa K. Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J Neurosci. 2008;28:8772-8784.
8. Vahtola E, Louhelainen M, Merasto S, Martonen E, Penttinen S, Aahos I, et al. Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat. J Hypertens. 2008;26:334-344.
9. Borradaile NM, Pickering JG. NAD (+), sirtuins, and cardiovascular disease. Curr Pharm Des. 2009;15:110-117.
10. Oliva J, French BA, Li J, Bardag-Gorce F, Fu P, French SW. Sirt1 is involved in energy metabolism: The role of chronic ethanol feeding and resveratrol. Exp Mol Pathol. 2008;85: 155-159.
11. Ghosh HS. The anti-aging, metabolism potential of SIRT1. Curr Opin Investig Drugs. 2008;9:1095-1102.
12. Alcaín FJ, Villalba JM. Sirtuin activators. Expert Opin Ther Pat. 2009;19:403-414.
13. Shin SM, Cho IJ, Kim SG. Resveratrol protects mitochondria against oxidative stress through AMPK-mediated GSK3 {beta} inhibition downstream of poly[ADP-ribose]polymerase- LKB1 pathway. Mol Pharmacol. 2009;76:884-895.
14. Hossain MB, Ji P, Anish R, Jacobson RH, Takada S. Polymerase 1 Interacts with nuclear respiratory factor 1 [NRF-1] and plays a role in NRF-1 transcriptional Regulation. J Biol Chem. 2009;284:8621-8632.
15. Viña J, Gomez-Cabrera MC, Borras C, Froio T, Sanchis-Gomar F, Martinez-Bello VE, et al. Mitochondrial biogenesis in exercise and in ageing. Adv Drug Deliv Rev. 2009;61:1369-1374.
16. Bohlender J, Fukamizu A, Lippoldt A, Nomura T, Dietz R, Ménard J, et al. High human renin hypertension in transgenic rats. Hypertension. 1997;29:428-434. (Pubitemid 27074079)
17. Ganten D, Wagner J, Zeh K, Bader M, Michel JB, Paul M, et al. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci USA. 1992;89:7806-7810.
18. Louhelainen M, Vahtola E, Kaheinen P, Leskinen H, Merasto S, Kytö V, et al. Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats. Br J Pharmacol. 2007;150:851-861.
19. Heyen JR, Blasi ER, Nikula K, Rocha R, Daust HA, Frierdich G, et al. Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Heart Circ Physiol. 2002;283:H1775-H1784.
20. Bastide K, Guilly MN, Bernaudin JF, Joubert C, Lectard B, Levalois C, et al. Molecular analysis of the Ink4a/Rb1-Arf/ Tp53 pathways in radon-induced rat lung tumors. Lung Cancer. 2009;63:348-353.
21. Wellner M, Dechend R, Park JK, Shagdarsuren E, Al-Saadi N, Kirsch T, et al. Cardiac gene expression profile in rats with terminal heart failure and cachexia. Physiol Genomics. 2005;20:256-267.
22. Chlopciíková S, Psotová J, Miketová P. Neonatal rat cardiomyocytes - A model for the study of morphological, biochemical and electrophysiological characteristics of the heart. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2001;145:49-55.
23. Rapp JP, Dene H. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension. 1985;7:340-349. (Pubitemid 15021172)
24. Walder RY, Morgan DA, Haynes WG, Sigmund RD, McClain AM, Stokes JB, et al. Genetic characterization of the "new" Harlan Sprague - Dawley Dahl salt-sensitive rats. Hypertension. 1996;27:546-551.
25. Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, et al. Resveratrol induces mitochondrial biogenesis in endothelial cells, Am J Physiol Heart Circ Physiol. 2009; 297:H13-H20.
26. M ü ller DN, Mervaala EM, Dechend R, Fiebeler A, Park JK, Schmidt F, et al. Angiotensin II (AT (1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. Am J Pathol. 2000;157:111-122.
27. Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F, et al. Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol. 2002;161:1679-1693. (Pubitemid 35265527)
28. Helkamaa T, Finckenberg P, Louhelainen M, Merasto S, Rauhala P, Lapatto R, et al. Entacapone protects from angiotensin II-induced infl ammation and renal injury. J Hypertens. 2003;21:2353-2363. (Pubitemid 38293576)
29. Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, et al. Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the saltsensitive hypertensive rat. Hypertension 2007;50:657-662.
30. Finkel T, Deng CX, Mostoslavsky. Recent progress in the biology and physiology of sirtuins. Nature 2009;460: 587-591.
31. Civitarese AE, Carling S, Heilbronn LK, Hulver MH, Ukropcova B, Deutsch WA, et al. CALERIE Pennington Team. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007;4:e76.
32. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res. 2007;100:1512-1521.
33. López-Lluch G, Irusta PM, Navas P, de Cabo R, Mitochondrial biogenesis and healthy aging. Exp Gerontol. 2008;43:813-819.
34. Borra MT, Smith BC, Denu JM. Mechanisms of human SIRT1 activation by resveratrol. J Biol Chem. 2005;280: 17187-17195.
35. Kaeberlein M, McDonaugh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, et al. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 2005;280:17038-17045.
36. Haigis MC, Sinclair DA. Mammalian sirtuins: Biological insights and disease relevance. Annu Rev Pathol. 2010;5: 253-295.
37. Stevens MJ, Li F, Drel VR, Abatan OI, Kim H, Burnett D, et al. Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats. J Pharmacol Exp Ther. 2007;320:458-464.
38. J Huang D, Wang Y, Yang C, Liao Y, Huang K. Angiotensin II promotes poly[ADP-ribosyl]ation of c-Jun/c-Fos in cardiac fibroblasts. Mol Cell Cardiol. 2009;46:25-32.
39. Pillai JB, Gupta M, Rajamohan SB, Lang R, Raman J, Gupta MP. Poly (ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2006;291:H1545-H1553.
40. Rajamohan SB, Pillai VB, Gupta M, Sundaresan NR, Birukov KG, Samant S, et al. SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly (ADP-ribose) polymerase 1. Mol Cell Biol. 2009;29:4116-4129.
41. Mervaala E, Biala A, Merasto S, Lempiä i nen J, Mattila I, Martonen E, et al. Metabolomics in angiotensin II-induced cardiac hypertrophy. Hypertension. 2010;55:508-515.
42. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006;127:1109-1122.
43. Fiebeler A, Schmidt F, Mü ller DN, Park JK, Dechend R, Bieringer M, et al. Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II induced cardiac injury. Hypertension 2001;37:787-793.
44. Miyazaki R, Ichiki T, Hashimoto T, Inanaga K, Imayama I, Sadoshima J, Sunagawa K. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2008;28:1263-1269.